Photosensitive rash induced by nivolumab

Detalhes bibliográficos
Autor(a) principal: Navarro-Triviño,Francisco J.
Data de Publicação: 2022
Outros Autores: Ruiz-Villaverde,Ricardo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000500648
Resumo: Abstract The therapeutic approach to metastatic melanoma has revolutionized the clinical course of this disease. Since 2011, different immunotherapeutic drugs have been approved. Nivolumab is a humanized immunoglobulin IgG4 monoclonal antibody that binds to the PD-1 receptor, blocking its interaction with his ligand PD-L1. The authors present a new case of photosensitivity induced by nivolumab. The photo exposed distribution of the eruption, the sun exposure prior to the beginning of the eruption, and the chronological relationship with the beginning of the treatment are data that have allowed us to confirm the suspected clinical diagnosis.
id SBD-1_1a590f31a3b5a20ae9dc71f69db9e23f
oai_identifier_str oai:scielo:S0365-05962022000500648
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Photosensitive rash induced by nivolumabMelanomaPatch testsPhotobiologyAbstract The therapeutic approach to metastatic melanoma has revolutionized the clinical course of this disease. Since 2011, different immunotherapeutic drugs have been approved. Nivolumab is a humanized immunoglobulin IgG4 monoclonal antibody that binds to the PD-1 receptor, blocking its interaction with his ligand PD-L1. The authors present a new case of photosensitivity induced by nivolumab. The photo exposed distribution of the eruption, the sun exposure prior to the beginning of the eruption, and the chronological relationship with the beginning of the treatment are data that have allowed us to confirm the suspected clinical diagnosis.Sociedade Brasileira de Dermatologia2022-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000500648Anais Brasileiros de Dermatologia v.97 n.5 2022reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1016/j.abd.2021.07.007info:eu-repo/semantics/openAccessNavarro-Triviño,Francisco J.Ruiz-Villaverde,Ricardoeng2022-09-27T00:00:00Zoai:scielo:S0365-05962022000500648Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2022-09-27T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Photosensitive rash induced by nivolumab
title Photosensitive rash induced by nivolumab
spellingShingle Photosensitive rash induced by nivolumab
Navarro-Triviño,Francisco J.
Melanoma
Patch tests
Photobiology
title_short Photosensitive rash induced by nivolumab
title_full Photosensitive rash induced by nivolumab
title_fullStr Photosensitive rash induced by nivolumab
title_full_unstemmed Photosensitive rash induced by nivolumab
title_sort Photosensitive rash induced by nivolumab
author Navarro-Triviño,Francisco J.
author_facet Navarro-Triviño,Francisco J.
Ruiz-Villaverde,Ricardo
author_role author
author2 Ruiz-Villaverde,Ricardo
author2_role author
dc.contributor.author.fl_str_mv Navarro-Triviño,Francisco J.
Ruiz-Villaverde,Ricardo
dc.subject.por.fl_str_mv Melanoma
Patch tests
Photobiology
topic Melanoma
Patch tests
Photobiology
description Abstract The therapeutic approach to metastatic melanoma has revolutionized the clinical course of this disease. Since 2011, different immunotherapeutic drugs have been approved. Nivolumab is a humanized immunoglobulin IgG4 monoclonal antibody that binds to the PD-1 receptor, blocking its interaction with his ligand PD-L1. The authors present a new case of photosensitivity induced by nivolumab. The photo exposed distribution of the eruption, the sun exposure prior to the beginning of the eruption, and the chronological relationship with the beginning of the treatment are data that have allowed us to confirm the suspected clinical diagnosis.
publishDate 2022
dc.date.none.fl_str_mv 2022-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000500648
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000500648
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.abd.2021.07.007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.97 n.5 2022
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126424967282688

Registros relacionados